Literature DB >> 14718334

Risks and benefits of statins in lupus erythematosus.

Bernard Noël.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14718334     DOI： 10.1001/archinte.164.1.107-b

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  2 in total

1.  A pravastatin dose-escalation study in systemic lupus erythematosus.

Authors:  Karen H Costenbader; Matthew H Liang; Lori B Chibnik; Juliet Aizer; Hannah Kwon; Victoria Gall; Elizabeth W Karlson
Journal:  Rheumatol Int       Date:  2007-04-03       Impact factor: 2.631

2.  Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study.

Authors:  Wojciech Plazak; Krzysztof Gryga; Hanna Dziedzic; Lidia Tomkiewicz-Pajak; Malgorzata Konieczynska; Piotr Podolec; Jacek Musial
Journal:  Arthritis Res Ther       Date:  2011-07-20       Impact factor: 5.156
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.